Altium Capital Management LP - Q3 2016 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q3 2016
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
FAT BRANDS INC15Q2 20240.6%
XTANT MED HLDGS INC13Q2 20246.2%
SURROZEN INC12Q2 20240.0%
ADMA BIOLOGICS INC11Q2 20246.9%
CHINOOK THERAPEUTICS INC11Q2 20238.9%
INSMED INC11Q2 20245.2%
NEXGEL INC11Q2 20240.1%
NOCTURNE ACQUISITION CORP11Q1 20240.1%
CINGULATE INC11Q2 20240.1%
NLS PHARMACEUTICS LTD11Q2 20240.0%

View Altium Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Altium Capital Management LP Q3 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
CEMTREX INCMay 08, 202436,98410.0%
Sunshine Biopharma, IncFebruary 21, 20243,727,98410.0%
Evoke Pharma IncFebruary 20, 2024822,9869.7%
ALIMERA SCIENCES INCFebruary 13, 20242,660,0005.0%
Cyclacel Pharmaceuticals, Inc.February 13, 202437,9825.0%
GRI BIO, Inc.February 13, 20241,269,2105.0%
Marpai, Inc.Sold outFebruary 13, 202400.0%
NovaBay Pharmaceuticals, Inc.February 13, 202467,4575.0%
Volcon, Inc.February 13, 20241,666,6659.9%
Xtant Medical Holdings, Inc.February 13, 20248,027,5936.2%

View Altium Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-08-26
SC 13G2024-08-16
13F-HR2024-08-15
SC 13G2024-08-09
SC 13G2024-08-09
13F-HR2024-05-15
SC 13G2024-05-08
SC 13G2024-02-21
SC 13G2024-02-20
13F-HR2024-02-14

View Altium Capital Management LP's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Altium Capital Management LP's holdings

CSVXLS